Cargando…
Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer
SIMPLE SUMMARY: Recently, immunotherapy has presented new opportunities for clinical development in the treatment of non-small cell lung cancer (NSCLC). Although effective in sustaining overall survival in several clinical trials, not all the NSCLC patients respond to these treatments. Thus, a bette...
Autores principales: | Ghini, Veronica, Laera, Letizia, Fantechi, Beatrice, del Monte, Francesca, Benelli, Matteo, McCartney, Amelia, Tenori, Leonardo, Luchinat, Claudio, Pozzessere, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760033/ https://www.ncbi.nlm.nih.gov/pubmed/33265926 http://dx.doi.org/10.3390/cancers12123574 |
Ejemplares similares
-
Evidence of a DHA Signature in the Lipidome and Metabolome of Human Hepatocytes
por: Ghini, Veronica, et al.
Publicado: (2017) -
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer
por: Vignoli, Alessia, et al.
Publicado: (2021) -
High‐Throughput Metabolomics by 1D NMR
por: Vignoli, Alessia, et al.
Publicado: (2018) -
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification
por: McCartney, Amelia, et al.
Publicado: (2019) -
DHA-Induced Perturbation of Human Serum Metabolome. Role of the Food Matrix and Co-Administration of Oat β-glucan and Anthocyanins
por: Ghini, Veronica, et al.
Publicado: (2019)